Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Fine Chemical Intermediates. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Discover a novel multi-component method for synthesizing carbonyl-bridged biheterocycles using safe CO substitutes, offering significant cost reduction in API manufacturing.
Novel Pd-catalyzed multicomponent method for indolinone-imidazole derivatives. Safe, scalable, CO-free process for high-purity pharmaceutical intermediates.
Novel palladium-catalyzed aminocarbonylation route for quinolin-2(1H)-ones using benzisoxazole. High yields, scalable process for pharmaceutical intermediates.
Patent CN115353511A details a novel multi-component Pd-catalyzed method for synthesizing carbonyl-bridged biheterocycles, offering safer conditions and cost reduction in API manufacturing.
Patent CN115353511A details a novel Pd-catalyzed multicomponent synthesis for carbonyl-bridged biheterocycles, offering cost reduction in pharmaceutical intermediate manufacturing.
Patent CN112480015B reveals a one-pot method for 2-trifluoromethyl quinazolinones, offering high yields and scalable pharma intermediate production.
Novel copper-catalyzed route for polyfluoroalkyl indolines. Reduces cost vs palladium methods. High purity pharmaceutical intermediates available.
Novel Pd-catalyzed serial cyclization method offers high purity beta-halopyrroles with simplified supply chains and cost-effective manufacturing for global pharma.
Patent CN108863969B reveals a mild Pd-catalyzed route for high-purity isoxazole intermediates, offering significant cost reduction and scalable manufacturing for global supply chains.
Patent CN112480015B details a scalable Pd-catalyzed one-pot method for quinazolinones, offering cost reduction in API manufacturing and reliable supply chain solutions.
Patent CN113105402B reveals a metal-free iodine-promoted synthesis for trifluoromethylated triazoles, offering significant cost reduction in API manufacturing and scalable production.
Patent CN113105402B reveals a metal-free iodine-promoted route for trifluoromethyl-triazoles, offering significant cost reduction in API manufacturing and simplified purification.
Patent CN107602570A reveals efficient Ugi-based synthesis for nitrogenous heterocycles, offering cost reduction and scalable supply chain solutions for pharmaceutical intermediates.
Patent CN113307790B reveals a metal-free oxidative cyclization route for high-purity triazole intermediates, offering significant cost reduction and scalable manufacturing for global supply chains.
Patent CN110746336B reveals a green, solvent-free iodine-catalyzed route for N-methyl-2-cyano-3-arylpyrrole intermediates, offering high atom efficiency and simplified purification for API manufacturing.
Patent CN112812032A reveals a green route to acetamides using dimethyl carbonate, offering cost-effective solutions for pharmaceutical intermediate manufacturing.
Patent CN115353511A details a safe, multi-component synthesis of carbonyl-bridged biheterocycles using formic acid as a CO source, offering significant cost reduction in API manufacturing.
Patent CN115353511A details a safe, multi-component synthesis of carbonyl-bridged biheterocycles using formic acid as a CO source, offering significant cost reduction in API manufacturing.
Patent CN115353511A details a novel Pd-catalyzed multi-component synthesis for carbonyl-bridged biheterocycles, offering safer conditions and cost reduction in API manufacturing.
Patent CN113105402B reveals a metal-free iodine-promoted route for 3,4,5-trisubstituted 1,2,4-triazoles, offering significant cost reduction in API manufacturing.